PenderFund Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

PenderFund Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,800	Closed	-$575K	–	239
2026 Q1	$575K	Buy	+26,800	New	+$378K	0.09%	71

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PenderFund Capital Management's DAWN Position: Q2 2026 in Review

PenderFund Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 26,800 shares — an estimated $575K sold.

PenderFund Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $575K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

PenderFund Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
PenderFund Capital Management sold 26,800 Day One Biopharmaceuticals shares in Q2 2026, an estimated $575K.
PenderFund Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
PenderFund Capital Management's Day One Biopharmaceuticals position peaked at $575K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on PenderFund Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.